The IgG2 Isotype of Anti –Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis

ConclusionOur findings indicate that anti ‐TIF1γ IgG2 is a potential new biomarker of cancer that should be helpful in identifying the risk of mortality in anti‐TIF1γ–positive DM patients.

Source: Arthritis and Rheumatology - July 7, 2019 Category: Rheumatology Authors: Audrey Aussy, Manuel Fr éret, Laure Gallay, Didier Bessis, Thierry Vincent, Denis Jullien, Laurent Drouot, Fabienne Jouen, Pascal Joly, Isabelle Marie, Alain Meyer, Jean Sibilia, Brigitte Bader‐Meunier, Eric Hachulla, Mohammed Hamidou, S Tags: Original Article Source Type: research